FENC insider trading — Fennec Pharmaceuticals Inc.
Over the last 90 days, insiders at Fennec Pharmaceuticals Inc. (FENC) made 0 open-market purchases worth $0 and 1 open-market sale worth $146K, making them net sellers by $146K. The largest sale was by Sayad Pierre Sargis (Chief Medical Officer), who sold 12,000 shares for $146K on Aug 31, 2026.
Updated Oct 16, 2026.
Recent FENC insider transactions
Every Form 4 filed by Fennec Pharmaceuticals Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | A · Grant/award | Direct | 3,846 | $5.53 | $21K | Form 4 |
| Oct 12, 2026 | Hackman Jeffrey S. | Chief Executive Officer | A · Grant/award | Direct | 2,224 | $5.53 | $12K | Form 4 |
| Oct 12, 2026 | Evans Terry L | Chief Commercial Officer | A · Grant/award | Direct | 2,326 | $5.53 | $13K | Form 4 |
| Oct 12, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | A · Grant/award | Direct | 3,946 | $5.53 | $22K | Form 4 |
| Oct 12, 2026 | Sayad Pierre Sargis | Chief Medical Officer | A · Grant/award | Direct | 3,846 | $5.53 | $21K | Form 4 |
| Sep 30, 2026 | Hackman Jeffrey S. | Chief Executive Officer | A · Grant/award | Direct | 1,159 | — | — | Form 4 |
| Sep 30, 2026 | Sayad Pierre Sargis | Chief Medical Officer | A · Grant/award | Direct | 168 | — | — | Form 4 |
| Sep 30, 2026 | Evans Terry L | Chief Commercial Officer | A · Grant/award | Direct | 168 | — | — | Form 4 |
| Sep 30, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | A · Grant/award | Direct | 156 | — | — | Form 4 |
| Sep 30, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | A · Grant/award | Direct | 1,703 | — | — | Form 4 |
| Sep 15, 2026 | Brughera Marco Maria | Director | M · Option exercise · 10b5-1 | Direct | 15,545 | $2.11 | $33K | Form 4 |
| Sep 15, 2026 | Brughera Marco Maria | Director | S · Sale · 10b5-1 | Direct | 15,545 | $10.29 | $160K | Form 4 |
| Sep 1, 2026 | Raykov Rosty | - | S · Sale · 10b5-1 | Direct | 10,000 | $12.11 | $121K | Form 4 |
| Aug 31, 2026 | Raykov Rosty | - | A · Grant/award · 10b5-1 | Direct | 2,778 | — | — | Form 4 |
| Aug 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | A · Grant/award | Direct | 168 | — | — | Form 4 |
| Aug 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | S · Sale | Direct | 12,000 | $12.18 | $146K | Form 4 |
| Aug 31, 2026 | Evans Terry L | Chief Commercial Officer | A · Grant/award | Direct | 168 | — | — | Form 4 |
| Aug 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | A · Grant/award | Direct | 156 | — | — | Form 4 |
| Aug 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer | A · Grant/award | Direct | 1,159 | — | — | Form 4 |
| Aug 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | A · Grant/award | Direct | 1,703 | — | — | Form 4 |
| Aug 28, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | M · Option exercise · 10b5-1 | Direct | 21,928 | $5.10 | $112K | Form 4 |
| Aug 27, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | S · Sale · 10b5-1 | Direct | 75,000 | $11.78 | $884K | Form 4 |
| Aug 3, 2026 | Raykov Rosty | - | S · Sale · 10b5-1 | Direct | 10,000 | $9.58 | $96K | Form 4 |
| Jul 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | A · Grant/award | Direct | 1,703 | — | — | Form 4 |
| Jul 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer | A · Grant/award | Direct | 1,159 | — | — | Form 4 |
| Jul 31, 2026 | Raykov Rosty | - | A · Grant/award | Direct | 2,778 | — | — | Form 4 |
| Jul 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | A · Grant/award | Direct | 156 | — | — | Form 4 |
| Jul 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | A · Grant/award | Direct | 168 | — | — | Form 4 |
| Jul 31, 2026 | Evans Terry L | Chief Commercial Officer | A · Grant/award | Direct | 168 | — | — | Form 4 |
FENC insider trading FAQ
Are insiders buying FENC stock?
Not on the open market. In the last 90 days, Fennec Pharmaceuticals Inc. insiders made no open-market purchases, and 1 open-market sale totaling $146K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading FENC?
Recent sellers: Sayad Pierre Sargis.
Where does FENC insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.